Abstract
Vladyslav Sikora, Maria Bove, Lisa Pia Agosti, Rossella Pia Palmieri, Mohsin Zafar, Paolo Tucci, Maria Grazia Morgese, Stefania Schiavone, Luigia Trabace
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1007/s00394-020-02322-0
10.1007/s00394-020-02322-0
Toll‐like receptors, NF‐κB, and IL‐27 mediate adenosine A2A receptor signaling in BTBR T(+) Itpr3(tf)/J mice
10.1016/j.pnpbp.2017.06.034 · 2017
Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL‐17A, RORγt, and T‐bet signaling, in the BTBR mouse model of autism
10.1016/j.brainresbull.2018.08.020 · 2018
10.1016/j.cellsig.2018.09.006
10.1016/j.cellsig.2018.09.006
The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim‐3 and Th17/Treg‐related signaling in the BTBR autistic mouse model
10.1016/j.neuint.2018.09.006 · 2018
10.5409/wjcp.v13.i4.99649
10.5409/wjcp.v13.i4.99649
10.1111/bph.70230
10.1111/bph.70230
10.1111/bph.70234
10.1111/bph.70234
10.1111/bph.70233
10.1111/bph.70233
10.1111/bph.70229
10.1111/bph.70229
10.1111/bph.14112
10.1111/bph.14112
10.3390/toxics11060546
10.3390/toxics11060546
10.1007/s12035-025-04894-6
10.1007/s12035-025-04894-6
10.1016/j.mcn.2017.04.012
10.1016/j.mcn.2017.04.012
10.3390/ani13193063
10.3390/ani13193063
10.1128/mcb.00099-20
10.1128/mcb.00099-20
10.1016/j.mcn.2016.09.004
10.1016/j.mcn.2016.09.004
10.3390/biomedicines13061420
10.3390/biomedicines13061420
Sulforaphane—A compound with potential health benefits for disease prevention and treatment: Insights from pharmacological and toxicological experimental studies
10.3390/antiox13020147 · 2024
10.1186/s13229-018-0218-4
10.1186/s13229-018-0218-4
10.1038/s41380-025-02967-5
10.1038/s41380-025-02967-5
10.3389/fncel.2025.1601366
10.3389/fncel.2025.1601366
10.1016/j.pnpbp.2024.110945
10.1016/j.pnpbp.2024.110945
10.1038/s41398-024-02905-z
10.1038/s41398-024-02905-z
10.1016/j.neuropharm.2024.110134
10.1016/j.neuropharm.2024.110134
10.1016/j.bbi.2014.06.006
10.1016/j.bbi.2014.06.006
The association between prenatal oxidative stress levels measured by isoprostanes and offspring neurodevelopmental outcomes at 36 months
10.1016/j.bbih.2024.100775 · 2024
10.1186/s13041-020-00649-7
10.1186/s13041-020-00649-7
10.1016/j.euroneuro.2020.12.002
10.1016/j.euroneuro.2020.12.002
10.1038/s41573-018-0008-x
10.1038/s41573-018-0008-x
10.1111/bph.17441
10.1111/bph.17441
10.1016/j.redox.2025.103661
10.1016/j.redox.2025.103661
10.1016/j.tifs.2017.02.002
10.1016/j.tifs.2017.02.002
10.1007/s13311-015-0360-z
10.1007/s13311-015-0360-z
10.1002/npr2.12112
10.1002/npr2.12112
10.3390/genes14030677
10.3390/genes14030677
10.1016/j.ntt.2012.07.006
10.1016/j.ntt.2012.07.006
10.1111/j.1471-4159.2010.07104.x
10.1111/j.1471-4159.2010.07104.x
10.3389/fpsyg.2019.00168
10.3389/fpsyg.2019.00168
10.7554/elife.54822
10.7554/elife.54822
Autism spectrum disorder: Pathogenesis, biomarker, and intervention therapy
10.1002/mco2.497 · doi-reference
10.1038/s41398-020-0699-8
10.1038/s41398-020-0699-8 · doi-reference
10.1007/s12011-022-03548-1
10.1007/s12011-022-03548-1 · doi-reference
10.1016/j.jnutbio.2016.10.004
10.1016/j.jnutbio.2016.10.004 · doi-reference
10.18632/aging.100733
10.18632/aging.100733 · doi-reference
10.3390/antiox13081012
10.3390/antiox13081012 · doi-reference
10.1155/anu/6665220
10.1155/anu/6665220 · doi-reference
Sulforaphane inhibits blue light‐induced inflammation and apoptosis by upregulating the SIRT1/PGC‐1alpha/Nrf2 pathway and autophagy in retinal pigment epithelial cells
10.1016/j.taap.2021.115545 · doi-reference
10.1007/s10803-021-04897-x
10.1007/s10803-021-04897-x · doi-reference
10.1002/dneu.22952
10.1002/dneu.22952 · doi-reference
10.1038/tp.2014.69
10.1038/tp.2014.69 · doi-reference
10.3390/pharmaceutics13070958
10.3390/pharmaceutics13070958 · doi-reference
10.1002/mnfr.201700911
10.1002/mnfr.201700911 · doi-reference
10.1038/npp.2009.201
10.1038/npp.2009.201 · doi-reference
10.1371/journal.pone.0127244
10.1371/journal.pone.0127244 · doi-reference
10.1007/s11011-023-01224-4
10.1007/s11011-023-01224-4 · doi-reference
10.3390/ijms26157498
10.3390/ijms26157498 · doi-reference
10.3390/antiox11040648
10.3390/antiox11040648 · doi-reference
10.1016/j.bbih.2024.100839
10.1016/j.bbih.2024.100839 · doi-reference
10.3390/antiox10111702
10.3390/antiox10111702 · doi-reference
10.1007/s00702-013-1083-0
10.1007/s00702-013-1083-0 · doi-reference
10.1124/jpet.116.237503
10.1124/jpet.116.237503 · doi-reference
10.1186/s13052-022-01310-w
10.1186/s13052-022-01310-w · doi-reference
10.1017/jns.2025.10033
10.1017/jns.2025.10033 · doi-reference
10.1016/j.jpsychires.2019.05.019
10.1016/j.jpsychires.2019.05.019 · doi-reference
10.3390/antiox9060521
10.3390/antiox9060521 · doi-reference
10.1002/npr2.12060
10.1002/npr2.12060 · doi-reference
10.1371/journal.pbio.3000410
10.1371/journal.pbio.3000410 · doi-reference
10.1016/j.pnpbp.2025.111362
10.1016/j.pnpbp.2025.111362 · doi-reference
10.3390/molecules28196902
10.3390/molecules28196902 · doi-reference
10.12659/msm.944161
10.12659/msm.944161 · doi-reference
10.1186/s12974-024-03106-7
10.1186/s12974-024-03106-7 · doi-reference
10.3389/fpsyt.2022.889636
10.3389/fpsyt.2022.889636 · doi-reference
10.3390/ijms26072916
10.3390/ijms26072916 · doi-reference
10.1016/j.pnpbp.2021.110249
10.1016/j.pnpbp.2021.110249 · doi-reference
10.1016/j.pnpbp.2017.12.015
10.1016/j.pnpbp.2017.12.015 · doi-reference
10.1016/j.bbr.2019.02.031
10.1016/j.bbr.2019.02.031 · doi-reference
10.1016/j.intimp.2020.107323
10.1016/j.intimp.2020.107323 · doi-reference
10.1016/j.pnpbp.2018.09.012
10.1016/j.pnpbp.2018.09.012 · doi-reference
10.1038/s41598-019-49781-y
10.1038/s41598-019-49781-y · doi-reference